FDA illustrates change controls for locally adapted and retrained medical AI
Source publication date
Site published
The examples address hospital-specific sepsis alerts and periodic retraining of arrhythmia-detection software, emphasizing defined change boundaries, independent validation, controlled deployment and monitoring. Announcement basis: FDA's October 20, 2026 update list. Checked October 23, 2026.
Summary
FDA listed hypothetical PCCP examples on October 20. They are development references, not product clearances or deployments.
Editorial view
Editorial view: compare lifecycle validation and deployment controls as well as model performance.
Evidence and limitations
Hypothetical examples are not complete submission guidance or evidence of any company's clearance, clinical benefit or deployment.